Literature DB >> 10352169

The new immunology--the end of immunosuppressive drug therapy?

R S Schwartz.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10352169     DOI： 10.1056/NEJM199906033402209

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Autoimmune hepatitis.

Authors:  Heike Bantel; Christian P Strassburg; Michael P Manns
Journal:  Curr Gastroenterol Rep       Date:  2005-05

Review 2.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 3.  Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases.

Authors:  Prakash Manikwar; Paul Kiptoo; Ahmed H Badawi; Barlas Büyüktimkin; Teruna J Siahaan
Journal:  Med Res Rev       Date:  2011-03-23       Impact factor: 12.944

4.  Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells.

Authors:  J R Abrams; S L Kelley; E Hayes; T Kikuchi; M J Brown; S Kang; M G Lebwohl; C A Guzzo; B V Jegasothy; P S Linsley; J G Krueger
Journal:  J Exp Med       Date:  2000-09-04       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.